Cellectis Sa Stock In The News

CLLS Stock  USD 1.24  0.05  3.88%   
Our overall analysis of Cellectis' news coverage and content from conventional and social sources shows investors' bearish mood towards Cellectis SA. The specific impact of Cellectis news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Cellectis' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Cellectis headlines in addition to utilizing other, more conventional financial analysis modules. Check out Cellectis Backtesting and Cellectis Hype Analysis.

Cellectis Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
https://www.globenewswire.com/news-release/2025/01/28/3016305/0/en/Totus-Medicines-Appoints-Simon-Harnest-MSc-BSc-as-Chief-Financial-Officer.html
 Bullish
Yahoo News
Cellectis announces the drawdown of the ...
https://finance.yahoo.com/news/cellectis-announces-drawdown-second-tranche-213000434.html
 Bullish
Yahoo News
Monthly information on share capital and company voting rights
https://finance.yahoo.com/news/monthly-information-share-capital-company-213000925.html
 Bullish
Yahoo News
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
https://finance.yahoo.com/news/cellectis-reports-results-shareholders-meeting-213000775.html
 Neutral
Yahoo News
Monthly information on share capital and company voting rights
https://finance.yahoo.com/news/monthly-information-share-capital-company-213000073.html
 Bullish
Macroaxis News: globenewswire.com
L’Assemblée Générale Extraordinaire de Cellectis se tiendra le 22 décembre 2023
https://www.globenewswire.com/news-release/2023/11/17/2782742/0/fr/L-Assembl%C3%A9e-G%C3%A9n%C3%A9rale-Extraordinaire-de-Cellectis-se-tiendra-le-22-d%C3%A9cembre-2023.html
 Neutral
Macroaxis News: globenewswire.com
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
https://www.globenewswire.com/news-release/2023/11/17/2782743/0/en/Cellectis-Shareholders-Meeting-to-be-Held-on-December-22-2023.html
 Neutral
Yahoo News
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
https://finance.yahoo.com/news/cellectis-shareholders-meeting-held-december-213000130.html
 Neutral
Macroaxis News: globenewswire.com
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
https://www.globenewswire.com/news-release/2023/11/15/2780728/0/en/Cellectis-Announces-the-execution-of-the-Subsequent-Investment-Agreement-with-AstraZeneca.html
 Neutral
Macroaxis News: globenewswire.com
Cellectis Annonce la signature de l’Accord d’Investissement Définitif avec AstraZeneca
https://www.globenewswire.com/news-release/2023/11/15/2780733/0/fr/Cellectis-Annonce-la-signature-de-l-Accord-d-Investissement-D%C3%A9finitif-avec-AstraZeneca.html
 Neutral

Cellectis SA Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Cellectis and other traded companies coverage with news coverage. We help investors stay connected with Cellectis headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Cellectis Stock performance. Please note that trading solely based on the Cellectis SA hype is not for everyone as timely availability and quick action are needed to avoid losses.
Cellectis' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Cellectis SA investors visualize upcoming and past events in order to time the market based on Cellectis SA noise-free hype analysis.
Cellectis stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Cellectis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Cellectis that are available to investors today. That information is available publicly through Cellectis media outlets and privately through word of mouth or via Cellectis internal channels. However, regardless of the origin, that massive amount of Cellectis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cellectis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cellectis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cellectis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cellectis alpha.

Cellectis Largest EPS Surprises

Earnings surprises can significantly impact Cellectis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-12-31
2024-12-31-0.21-0.160.0523 
2018-11-13
2018-09-30-0.61-0.540.0711 
2020-11-05
2020-09-30-0.61-0.69-0.0813 
2023-05-04
2023-03-31-0.48-0.58-0.120 
2015-11-19
2015-09-30-0.3-0.4-0.133 
2023-11-06
2023-09-30-0.42-0.310.1126 
View All Earnings Estimates

Cellectis Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Cellectis SA Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
13th of March 2025
Cellectis Reports Financial Resultsfor the Fourth Quarter and F
at gurufocus.com 
Macroaxis News: globenewswire.com
6th of March 2025
Information mensuelle relative au nombre total des droits de vote et dactions composant le...
at globenewswire.com 
Macroaxis News: globenewswire.com
24th of February 2025
Cellectis Presents Smart CAR T Strategy to Enhance Efficacy Against Solid Tumors at AACR-I...
at globenewswire.com 
Macroaxis News: globenewswire.com
4th of February 2025
Information mensuelle relative au nombre total des droits de vote et dactions composant le...
at globenewswire.com 
Yahoo News
7th of January 2025
Do Options Traders Know Something About Cellectis Stock We Dont
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cellectis in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cellectis' short interest history, or implied volatility extrapolated from Cellectis options trading.

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.